{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:27:17Z","timestamp":1707524837445},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,22]]},"DOI":"10.7759\/cureus.32835","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T18:18:14Z","timestamp":1671733094000},"source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Corticosteroid Therapy on Choroidal Thickness in Patients With Covid-19 Infection: A Prospective, Comparative, and Observational Study"],"prefix":"10.7759","author":[{"given":"Hatice Kubra","family":"Sonmez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Evereklioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Ture Yuce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duygu G","family":"Sevim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge","family":"Temizyurek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman Ahmet","family":"Polat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Horozoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta A","year":"2020","unstructured":"Gupta A, Madhavan MV, Sehgal K, et al.. Extrapulmonary manifestations of COVID-19. Nat Med. 2020, 26:1017-32. 10.1038\/s41591-020-0968-3","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)","volume":"251","author":"Bourgonje AR","year":"2020","unstructured":"Bourgonje AR, Abdulle AE, Timens W, et al.. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020, 251:228-48. 10.1002\/path.5471","journal-title":"J Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2021.102191","article-title":"Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis","volume":"44","author":"Zhong Y","year":"2021","unstructured":"Zhong Y, Wang K, Zhu Y, Lyu D, Yu Y, Li S, Yao K. Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis. Travel Med Infect Dis. 2021, 44:102191. 10.1016\/j.tmaid.2021.102191","journal-title":"Travel Med Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4827304","article-title":"Ocular findings in COVID-19 patients: a review of direct manifestations and indirect effects on the eye","volume":"2020","author":"Bertoli F","year":"2020","unstructured":"Bertoli F, Veritti D, Danese C, et al.. Ocular findings in COVID-19 patients: a review of direct manifestations and indirect effects on the eye. J Ophthalmol. 2020, 2020:4827304. 10.1155\/2020\/4827304","journal-title":"J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2021.102406","article-title":"Inner retinal layer ischemia and vision loss after COVID-19 infection: a case report","volume":"35","author":"Sonmez HK","year":"2021","unstructured":"Sonmez HK, Polat OA, Erkan G. Inner retinal layer ischemia and vision loss after COVID-19 infection: a case report. Photodiagnosis Photodyn Ther. 2021, 35:102406. 10.1016\/j.pdpdt.2021.102406","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000801","article-title":"Retinal and choroidal manifestations of COVID-19","volume":"32","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Stewart JM. Retinal and choroidal manifestations of COVID-19. Curr Opin Ophthalmol. 2021, 32:536-40. 10.1097\/ICU.0000000000000801","journal-title":"Curr Opin Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10204686","article-title":"COVID-19 associated choroidopathy","volume":"10","author":"Abdelmassih Y","year":"2021","unstructured":"Abdelmassih Y, Azar G, Bonnin S, et al.. COVID-19 associated choroidopathy. J Clin Med. 2021, 10:4686. 10.3390\/jcm10204686","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5935\/0004-2749.20230021","article-title":"Choroidal thickness changes in post-COVID-19 cases","author":"Konuk \u015eG","year":"2022","unstructured":"Konuk \u015eG, K\u0131l\u0131\u00e7 R, T\u00fcrky\u0131lmaz B, T\u00fcrko\u011flu E. Choroidal thickness changes in post-COVID-19 cases. Arq Bras Oftalmol. 2022, S0004-27492022005004204. 10.5935\/0004-2749.20230021","journal-title":"Arq Bras Oftalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2021.102674","article-title":"Change in retinal vessel diameter and choroidal thickness in patients with severe COVID-19: change in retinal parameters in patients with severe COVID-19","volume":"37","author":"G\u00fcndo\u011fan M","year":"2022","unstructured":"G\u00fcndo\u011fan M, Vural E, Bayram N, Altunel O, G\u00fcndo\u011fan F, G\u00f6kta\u015f S. Change in retinal vessel diameter and choroidal thickness in patients with severe COVID-19: change in retinal parameters in patients with severe COVID-19. Photodiagnosis Photodyn Ther. 2022, 37:102674. 10.1016\/j.pdpdt.2021.102674","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06573-1","article-title":"Dexamethasone 12\u00a0mg versus 6\u00a0mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial","volume":"48","author":"Granholm A","year":"2022","unstructured":"Granholm A, Munch MW, Myatra SN, et al.. Dexamethasone 12\u00a0mg versus 6\u00a0mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial. Intensive Care Med. 2022, 48:45-55. 10.1007\/s00134-021-06573-1","journal-title":"Intensive Care Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200012000-00016","article-title":"Ocular complications of topical, peri-ocular, and systemic corticosteroids","volume":"11","author":"Carnahan MC","year":"2000","unstructured":"Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000, 11:478-83. 10.1097\/00055735-200012000-00016","journal-title":"Curr Opin Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213110","article-title":"Central serous chorioretinopathy with and without steroids: a multicenter survey","volume":"14","author":"Araki T","year":"2019","unstructured":"Araki T, Ishikawa H, Iwahashi C, et al.. Central serous chorioretinopathy with and without steroids: a multicenter survey. PLoS One. 2019, 14:e0213110. 10.1371\/journal.pone.0213110","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1993.01090060119035","article-title":"The Lens Opacities Classification System III. The longitudinal study of cataract study group","volume":"111","author":"Chylack LT Jr","year":"1993","unstructured":"Chylack LT Jr, Wolfe JK, Singer DM, et al.. The Lens Opacities Classification System III. The longitudinal study of cataract study group. Arch Ophthalmol. 1993, 111:831-6. 10.1001\/archopht.1993.01090060119035","journal-title":"Arch Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12348-022-00297-z","article-title":"Spectral-domain optical coherence tomography assessment of retinal and choroidal changes in patients with coronavirus disease 2019: a case-control study","volume":"12","author":"Abrishami M","year":"2022","unstructured":"Abrishami M, Daneshvar R, Emamverdian Z, Saeedian N, Tohidinezhad F, Eslami S, Ansari-Astaneh MR. Spectral-domain optical coherence tomography assessment of retinal and choroidal changes in patients with coronavirus disease 2019: a case-control study. J Ophthalmic Inflamm Infect. 2022, 12:18. 10.1186\/s12348-022-00297-z","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2020.12.021","article-title":"Optical coherence tomography angiography findings in patients with COVID-19","volume":"56","author":"Turker IC","year":"2021","unstructured":"Turker IC, Dogan CU, Guven D, Kutucu OK, Gul C. Optical coherence tomography angiography findings in patients with COVID-19. Can J Ophthalmol. 2021, 56:83-7. 10.1016\/j.jcjo.2020.12.021","journal-title":"Can J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2021.06.020","article-title":"Long-term follow-up of choroidal changes following COVID-19 infection: analysis of choroidal thickness and choroidal vascularity index","author":"Hepokur M","year":"2021","unstructured":"Hepokur M, Gunes M, Durmus E, Aykut V, Esen F, Oguz H. Long-term follow-up of choroidal changes following COVID-19 infection: analysis of choroidal thickness and choroidal vascularity index. Can J Ophthalmol. 2021, 10.1016\/j.jcjo.2021.06.020","journal-title":"Can J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4123328","article-title":"Longitudinal alterations of retinal and choroidal structure in patients recovered from COVID-19","volume":"2022","author":"Abrishami M","year":"2022","unstructured":"Abrishami M, Hassanpour K, Zamani G, et al.. Longitudinal alterations of retinal and choroidal structure in patients recovered from COVID-19. J Ophthalmol. 2022, 2022:4123328. 10.1155\/2022\/4123328","journal-title":"J Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1990.39","article-title":"In vivo choroidal circulation and its watershed zones","volume":"4 (Pt 2)","author":"Hayreh SS","year":"1990","unstructured":"Hayreh SS. In vivo choroidal circulation and its watershed zones. Eye (Lond). 1990, 4 (Pt 2):273-89. 10.1038\/eye.1990.39","journal-title":"Eye (Lond)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001380","article-title":"Choroidal thickness of central serous chorioretinopathy secondary to corticosteroid use","volume":"37","author":"Honda S","year":"2017","unstructured":"Honda S, Miki A, Kusuhara S, Imai H, Nakamura M. Choroidal thickness of central serous chorioretinopathy secondary to corticosteroid use. Retina. 2017, 37:1562-7. 10.1097\/IAE.0000000000001380","journal-title":"Retina"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(02)01303-9","article-title":"Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies","volume":"109","author":"Jampol LM","year":"2002","unstructured":"Jampol LM, Weinreb R, Yannuzzi L. Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology. 2002, 109:1765-6. 10.1016\/s0161-6420(02)01303-9","journal-title":"Ophthalmology"},{"key":"ref22","article-title":"Can long-term corticosteriods lead to blindness? A case series of central serous chorioretinopathy induced by corticosteroids","volume":"35","author":"Loo JL","year":"2006","unstructured":"Loo JL, Lee SY, Ang CL. Can long-term corticosteriods lead to blindness? A case series of central serous chorioretinopathy induced by corticosteroids. Ann Acad Med Singap. 2006, 35:496-9.","journal-title":"Ann Acad Med Singap"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2017-000209","article-title":"Monitoring long-term oral corticosteroids","volume":"6","author":"Mundell L","year":"2017","unstructured":"Mundell L, Lindemann R, Douglas J. Monitoring long-term oral corticosteroids. BMJ Open Qual. 2017, 6:e000209. 10.1136\/bmjoq-2017-000209","journal-title":"BMJ Open Qual"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2020.09.15","article-title":"Choroidal changes in eyes treated with high-dose systemic corticosteroids for optic neuritis","volume":"13","author":"Lee JH","year":"2020","unstructured":"Lee JH, Lee JY, Ra H, Kang NY, Baek J. Choroidal changes in eyes treated with high-dose systemic corticosteroids for optic neuritis. Int J Ophthalmol. 2020, 13:1430-5. 10.18240\/ijo.2020.09.15","journal-title":"Int J Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2006.0067","article-title":"The etiology of steroid cataract","volume":"23","author":"James ER","year":"2007","unstructured":"James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther. 2007, 23:403-20. 10.1089\/jop.2006.0067","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-022-02217-5","article-title":"The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases","volume":"42","author":"Yan H","year":"2022","unstructured":"Yan H, Tan X, Yu J, Liang T, Shi W, Li L, Peng C. The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases. Int Ophthalmol. 2022, 42:2175-84. 10.1007\/s10792-022-02217-5","journal-title":"Int Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2018.01.017","article-title":"Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients","volume":"22","author":"Rice ML","year":"2018","unstructured":"Rice ML, Wong B, Horn PS, Yang MB. Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients. J AAPOS. 2018, 22:192-6. 10.1016\/j.jaapos.2018.01.017","journal-title":"J AAPOS"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/129205-the-effect-of-corticosteroid-therapy-on-choroidal-thickness-in-patients-with-covid-19-infection-a-prospective-comparative-and-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:21Z","timestamp":1707507981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/129205-the-effect-of-corticosteroid-therapy-on-choroidal-thickness-in-patients-with-covid-19-infection-a-prospective-comparative-and-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.32835","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,22]]}}}